Evaluation of (99m)Tc-HYNIC-TMTP1 as a tumor-homing imaging agent targeting metastasis with SPECT
- PMID: 25516099
- DOI: 10.1016/j.nucmedbio.2014.11.001
Evaluation of (99m)Tc-HYNIC-TMTP1 as a tumor-homing imaging agent targeting metastasis with SPECT
Abstract
Introduction: TMTP1 (NVVRQ) is a novel tumor-homing peptide, which specifically targets tumor metastases, even at the early stage of occult metastasis foci. Fusing TMTP1 to therapeutic peptides or proteins can increase its anti-cancer efficacy both in vivo and in vitro. Here, we labeled TMTP1 with (99m)Tc to evaluate its targeting properties in an ovarian cancer xenograft tumor mouse model and a gastric cancer xenograft mouse model.
Methods: The invasion ability of SKOV3 and highly metastatic SKOV3.ip cell lines were performed by the Transwell Invasion Assays, and then Rhodamine-TMTP1 was used to detect its affinity to these two cells. Using the co-ligand ethylenediamine-N, N'-diacetic acid (EDDA) and the bifunctional chelator 6-hydrazinonicotinic acid (HYNIC), the TMTP1 peptide was labeled with (99m)Tc. A cell-binding assay was performed by incubating cancer cells with (99m)Tc-HYNIC-TMTP1 with or without an excess dose of cold HYNIC-TMTP1. To evaluate the probe in vivo, nude mice bearing SKOV3, SKOV3.ip and MNK-45 tumor cells were established and subjected to SPECT imaging after injection with (99m)Tc-HYNIC-TMTP1. Ex vivo γ-counting of dissected tissues from the mice was used to evaluate its biodistribution.
Results: (99m)Tc-HYNIC-TMTP1 was successfully synthesized. The radiotracer also exhibited high hydrophilicity and excellent stability in vitro and in vivo. It has strong affinity to highly metastatic cancer cell lines but not to poorly metastatic cell lines. After mice were injected with (99m)Tc-HYNIC-TMTP1, non-invasive SPECT imaging detected SKOV3.ip and MNK-45 xenograft tumors but not SKOV3 xenograft tumors. This result can be inhibited by excess HYNIC-TMTP1. The uptake of (99m)Tc-HYNIC-TMTP1 in SKOV3.ip xenograft tumors was 0.182±0.017% ID/g at 2h p.i. with high renal uptake (74.32±15.05% ID/g at 2h p.i.).
Conclusion: (99m)Tc-HYNIC-TMTP1 biodistribution and SPECT imaging demonstrated its ability to target highly metastatic tumors. Therefore, metastasis can be non-invasively investigated by SPECT imaging using (99m)Tc-HYNIC-TMTP1. Meanwhile, this radiotracer has some shortages in the low % ID/g of tumors and high accumulation in the kidney.
Keywords: (99m)Tc-HYNIC-TMTP1; Metastasis; Ovarian cancer; SPECT imaging; TMTP1; Tumor imaging.
Copyright © 2014 Elsevier Inc. All rights reserved.
Similar articles
-
(99m)Tc-labeled SWL specific peptide for targeting EphA2 receptor.Nucl Med Biol. 2014 Jul;41(6):450-6. doi: 10.1016/j.nucmedbio.2014.03.020. Epub 2014 Mar 29. Nucl Med Biol. 2014. PMID: 24768147
-
Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.Nucl Med Commun. 2014 Apr;35(4):423-32. doi: 10.1097/MNM.0000000000000065. Nucl Med Commun. 2014. PMID: 24335877
-
Development of a SPECT Tracer to Image c-Met Expression in a Xenograft Model of Non-Small Cell Lung Cancer.J Nucl Med. 2018 Nov;59(11):1686-1691. doi: 10.2967/jnumed.117.206730. Epub 2018 May 18. J Nucl Med. 2018. PMID: 29777004
-
99mTc-Ethylenenediamine-N,N'-diacetic acid/hydrazinonicotinamide[Lys3]-bombesin.2007 Aug 15 [updated 2007 Sep 19]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2007 Aug 15 [updated 2007 Sep 19]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20641296 Free Books & Documents. Review.
-
99mTc-Ethylenediaminediacetic acid/hydrazinonicotinic acid-[dGlu1, desGlu2–6]minigastrin.2007 May 4 [updated 2007 Jun 7]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2007 May 4 [updated 2007 Jun 7]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20641350 Free Books & Documents. Review.
Cited by
-
Lymph node metastasis in cancer progression: molecular mechanisms, clinical significance and therapeutic interventions.Signal Transduct Target Ther. 2023 Sep 27;8(1):367. doi: 10.1038/s41392-023-01576-4. Signal Transduct Target Ther. 2023. PMID: 37752146 Free PMC article. Review.
-
Tumor targeting peptide TMTP1 modified Antigen capture Nano-vaccine combined with chemotherapy and PD-L1 blockade effectively inhibits growth of ovarian cancer.J Nanobiotechnology. 2024 Aug 13;22(1):483. doi: 10.1186/s12951-024-02744-6. J Nanobiotechnology. 2024. PMID: 39138475 Free PMC article.
-
TMTP1-modified Indocyanine Green-loaded Polymeric Micelles for Targeted Imaging of Cervical Cancer and Metastasis Sentinel Lymph Node in vivo.Theranostics. 2019 Sep 25;9(24):7325-7344. doi: 10.7150/thno.35346. eCollection 2019. Theranostics. 2019. PMID: 31695771 Free PMC article.
-
XPNPEP2 is associated with lymph node metastasis in prostate cancer patients.Sci Rep. 2019 Jul 11;9(1):10078. doi: 10.1038/s41598-019-45245-5. Sci Rep. 2019. PMID: 31296901 Free PMC article.
-
Peptide-based imaging agents for cancer detection.Adv Drug Deliv Rev. 2017 Feb;110-111:38-51. doi: 10.1016/j.addr.2016.06.007. Epub 2016 Jun 18. Adv Drug Deliv Rev. 2017. PMID: 27327937 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical